Findings presented at the International VT Symposium and published simultaneously in Circulation.

CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA , Oct. 10, 2025 /PRNewswire/ -- Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter Ablation Study ( VCAS ), the first-in-human evaluation of its FieldForce™ Ablation System for ventricular tachycardia (VT). Results were also presented as a late-breaking trial at the 20th Annual International Symposium on Ventricular Arrhythmias (VT Symposium).

"This is the first time we've seen evidence that pulsed field ablation can reach deep scar tissue in the ventricle." — Vivek Reddy, M.D.

Results at Six Months

VCAS is a prospective, multicenter feasibility trial evaluating the safety

See Full Page